Skip to content

Adherence to Pharmacological Antiepileptic Treatment in Adolescence

Complexity and Specificity of Antiepileptic Drug Treatment and Adherence to Therapy in Adolescence. Pilot Study on Drug Perception and Factors That May Affect it

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05825807
Enrollment
100
Registered
2023-04-24
Start date
2020-11-12
Completion date
2024-11-12
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Treatment Adherence

Keywords

Adolescence, Antiepileptic therapy, Treatment Adherence, Perception

Brief summary

Epilepsy and its drug treatment affect fundamental aspects of an adolescent's lifestyle and can have major consequences on self-esteem and sense of identity. For many adolescents it is difficult to live with epilepsy and medication is difficult to accept; the side effects of medication, in particular even small changes in mental status and somatic appearance, are particularly feared and poorly tolerated. While it is true that drug-resistant epilepsies exist (about 30% of cases), it is also true that there exists a pseudo-resistance to drug treatment which is due to inadequate administration or poor adherence to treatment. It is estimated that 21 to 42% of patients on antiepileptic treatment don't adhere to the prescribed therapy. The literature emphasizes that non-adherence to treatment is a crucial problem for people with epilepsy, and that the adolescent population is particularly at risk. As with any chronic drug therapy, the therapeutic relationship plays an important role in the treatment of epilepsy. In adolescence, the communication that occurs within the therapeutic relationship takes on peculiar and specific aspects that go beyond the acquisition of anamnestic data and of what is usually reported explicitly in the interview. Communication must be centered on the adolescent's need for independence. Appropriate communication can make the adolescent feel more supported and can encourage him or her to gain self-awareness and control on decisions regarding his or her illness. For the physician, knowledge of the adolescent's point of view is indispensable in order to provide all the necessary information in an appropriate, understandable, and acceptable way, while at the same time acting as a mediator of communication. The objective of this project is to describe and analyze adolescents' perception of antiepileptic treatment, their awareness of the disease and of the need for drug treatment.

Interventions

None listed

Sponsors

IRCCS Burlo Garofolo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of epilepsy * Age between 12 and 18 years * On treatment with antiepileptic drugs for at least one year * Able to understand and complete the questionnaire

Exclusion criteria

* Subjects with moderate to severe intellectual disability

Design outcomes

Primary

MeasureTime frameDescription
To describe adolescent's perception of need for antiepileptic treatmentAt baselineEvaluated by the Antiepileptic drugs (AED) Necessity scale (6 items evaluating the perceived personal need for antiepileptic drugs). Each item provides 5 possible answers (1=strongly disagree, 2=disagree, 3=uncertain, 4=agree, 5=strongly agree)
To describe adolescent's concerns about potential adverse effects of antiepileptic drugsAt baselineEvaluated by the Antiepileptic drugs (AED)-Concerns scale (10 items evaluating concerns about potential adverse effects of antiepileptic drugs). Each item provides 5 possible answers (1=strongly disagree, 2=disagree, 3=uncertain, 4=agree, 5=strongly agree)

Secondary

MeasureTime frameDescription
To identify clinical factors influencing adolescent's perception of need for antiepileptic treatmentAt baselineClinical factors will be collected and association with AED-Necessity scale will be evaluated with multivariate analysis
To identify sociodemographic factors influencing adolescent's perception of need for antiepileptic treatmentAt baselineSociodemographic factors will be collected and association with AED-Necessity scale will be evaluated with multivariate analysis
To identify clinical factors influencing adolescent's concerns about potential adverse effects of antiepileptic drugsAt baselineClinical factors will be collected and association with AED-Concerns scale will be evaluated with multivariate analysis
To identify sociodemographic factors influencing adolescent's concerns about potential adverse effects of antiepileptic drugsAt baselineSociodemographic factors will be collected and association with AED-Concerns scale will be evaluated with multivariate analysis

Countries

Italy

Contacts

Primary ContactCaterina Zanus, MD
caterina.zanus@burlo.trieste.it+390403785214

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026